Literature DB >> 20453501

Analysis of segmental duplications, mouse genome synteny and recurrent cancer-associated amplicons in human chromosome 6p21-p12.

J W Martin1, M Yoshimoto, O Ludkovski, P S Thorner, M Zielenska, J A Squire, P A S Nuin.   

Abstract

It has been proposed that regions of microhomology in the human genome could facilitate genomic rearrangements, copy number transitions, and rapid genomic change during tumor progression. To investigate this idea, this study examines the role of repetitive sequence elements, and corresponding syntenic mouse genomic features, in targeting cancer-associated genomic instability of specific regions of the human genome. Automated database-mining algorithms designed to search for frequent copy number transitions and genomic breakpoints were applied to 2 publicly-available online databases and revealed that 6p21-p12 is one of the regions of the human genome most frequently involved in tumor-specific alterations. In these analyses, 6p21-p12 exhibited the highest frequency of genomic amplification in osteosarcomas. Analysis of repetitive elements in regions of homology between human chromosome 6p and the syntenic regions of the mouse genome revealed a strong association between the location of segmental duplications greater than 5 kilobase-pairs and the position of discontinuities at the end of the syntenic region. The presence of clusters of segmental duplications flanking these syntenic regions also correlated with a high frequency of amplification and genomic alteration. Collectively, the experimental findings, in silico analyses, and comparative genomic studies presented here suggest that segmental duplications may facilitate cancer-associated copy number transitions and rearrangements at chromosome 6p21-p12. This process may involve homology-dependent DNA recombination and/or repair, which may also contribute towards the overall plasticity of the human genome. 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20453501     DOI: 10.1159/000308353

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  10 in total

1.  Genomic promoter occupancy of runt-related transcription factor RUNX2 in Osteosarcoma cells identifies genes involved in cell adhesion and motility.

Authors:  Margaretha van der Deen; Jacqueline Akech; David Lapointe; Sneha Gupta; Daniel W Young; Martin A Montecino; Mario Galindo; Jane B Lian; Janet L Stein; Gary S Stein; Andre J van Wijnen
Journal:  J Biol Chem       Date:  2011-12-09       Impact factor: 5.157

Review 2.  F-box only protein 9 and its role in cancer.

Authors:  Shujaat Hussain; Jianshu Dong; Xinli Ma; Jian Li; Shen Chen; Agboybor Clement; Hongmin Liu
Journal:  Mol Biol Rep       Date:  2022-01-13       Impact factor: 2.316

3.  MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma.

Authors:  Margaretha van der Deen; Hanna Taipaleenmäki; Ying Zhang; Nadiya M Teplyuk; Anurag Gupta; Senthilkumar Cinghu; Kristen Shogren; Avudaiappan Maran; Michael J Yaszemski; Ling Ling; Simon M Cool; David T Leong; Christian Dierkes; Jozef Zustin; Manuel Salto-Tellez; Yoshiaki Ito; Suk-Chul Bae; Maria Zielenska; Jeremy A Squire; Jane B Lian; Janet L Stein; Gerard P Zambetti; Stephen N Jones; Mario Galindo; Eric Hesse; Gary S Stein; Andre J van Wijnen
Journal:  J Biol Chem       Date:  2013-05-29       Impact factor: 5.157

4.  Aberrant upregulation of LRRC1 contributes to human hepatocellular carcinoma.

Authors:  Yandong Li; Bo Zhou; Jihong Dai; Ruifang Liu; Ze-Guang Han
Journal:  Mol Biol Rep       Date:  2013-05-06       Impact factor: 2.316

5.  The cancer-related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell lines.

Authors:  Claudia M J Lucero; Oscar A Vega; Mariana M Osorio; Julio C Tapia; Marcelo Antonelli; Gary S Stein; Andre J van Wijnen; Mario A Galindo
Journal:  J Cell Physiol       Date:  2013-04       Impact factor: 6.384

Review 6.  Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies.

Authors:  James J Morrow; Chand Khanna
Journal:  Crit Rev Oncog       Date:  2015

7.  The genetics of osteosarcoma.

Authors:  Jeff W Martin; Jeremy A Squire; Maria Zielenska
Journal:  Sarcoma       Date:  2012-05-20

8.  Anesthetic management of a patient with chromosome 6p duplication: a case report.

Authors:  Saori Morinaga; Masanori Tsukamoto; Takeshi Yokoyama
Journal:  J Dent Anesth Pain Med       Date:  2017-06-29

Review 9.  Origin and Therapies of Osteosarcoma.

Authors:  Brice Moukengue; Morgane Lallier; Louise Marchandet; Marc Baud'huin; Franck Verrecchia; Benjamin Ory; Francois Lamoureux
Journal:  Cancers (Basel)       Date:  2022-07-19       Impact factor: 6.575

10.  Retrospective clinicopathological study of malignant bone tumors in children and adolescents in Romania - single center experience.

Authors:  R C Petca; S Gavriliu; G Burnei
Journal:  J Med Life       Date:  2016 Apr-Jun
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.